REMEDIUMREMEDIUM1561-59362658-3534Joint-Stock Company Chicot174910.32687/1561-5936-2025-29-1-24-27Original ArticleIssues of availability of narcotic and psychotropic medicines for the population of the Irkutsk regionРыжоваОльга Александровнаsamarar@rambler.ruМорозТатьяна Львовнаmoroz_tl@mail.ruIrkutsk State Medical Academy of Postgraduate Education — Branch Campus of the Russian Medical Academy of Continuing Professional Education, Irkutsk, Russia151220251242715102025Copyright © 2025,2025The accessibility of providing the population with narcotic analgesics in remote and hard-to-reach areas of three regions of Eastern Siberia — the Irkutsk region, the Republic of Buryatia and the Krasnoyarsk Territory — was studied. It has been established that the main reason is the low transport accessibility of the pharmacies in 23 (53%) areas with a population density of up to 5 people. per sq. km. The reduction in the number of municipal pharmacies in areas with low population in the Irkutsk region is being replaced by the involvement of privately owned joint-stock companies (25%) with a license for the circulation of NS and PV. The number of population per 1 pharmacy providing the population with narcotic and psychotropic drugs in the range of 45 thousand people was calculated. In the Irkutsk region. up to 41.2 thousand people in the Republic of Buryatia, which indicates common problems of increasing the availability of medicines in Eastern Siberia.availability of pain reliefnarcotic analgesics, remote and hard-to-reach areastransport accessibilitypharmacy organizationsдоступность обезболиваниянаркотические анальгетики, отдалённые и труднодоступные районытранспортная доступностьаптечные организации1.Petrukhina IK, Ryazanova ТK, Khusainova AI, et al. Analysis of the main indicative values of the pharmaceutical market retail sectors in the constituent entities of the Russian Federation. Farmakoekonomika. Modern Pharmacoeconomics and Pharmacoepidemiology. 2022;15(4):419—441. DOI: 10.17749/2070—4909/farmakoekonomika.2022.1472.Kovach A. S. Estimation of economic expenditures on adverse drug reactions during therapy. Farmatsiya (Pharmacy). 2019;68(1):42—47. DOI: 10.29296/25419218-2019-01-06